Novartis AG (NVSEF)
163.60
+5.99
(+3.80%)
USD |
OTCM |
Aug 24, 16:00
Novartis Price to Book Value : 7.209 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 7.209 |
| August 21, 2026 | 6.945 |
| August 20, 2026 | 6.945 |
| August 19, 2026 | 7.050 |
| August 18, 2026 | 6.598 |
| August 17, 2026 | 6.430 |
| August 14, 2026 | 6.958 |
| August 13, 2026 | 6.958 |
| August 12, 2026 | 6.958 |
| August 11, 2026 | 6.958 |
| August 10, 2026 | 6.672 |
| August 07, 2026 | 6.694 |
| August 06, 2026 | 6.694 |
| August 05, 2026 | 6.694 |
| August 04, 2026 | 6.694 |
| August 03, 2026 | 6.694 |
| July 31, 2026 | 6.985 |
| July 30, 2026 | 6.985 |
| July 29, 2026 | 6.985 |
| July 28, 2026 | 6.610 |
| July 27, 2026 | 6.610 |
| July 24, 2026 | 6.807 |
| July 23, 2026 | 6.807 |
| July 22, 2026 | 6.742 |
| July 21, 2026 | 6.742 |
| Date | Value |
|---|---|
| July 20, 2026 | 6.742 |
| July 17, 2026 | 6.693 |
| July 16, 2026 | 6.693 |
| July 15, 2026 | 6.440 |
| July 14, 2026 | 6.556 |
| July 13, 2026 | 6.771 |
| July 10, 2026 | 6.771 |
| July 09, 2026 | 7.050 |
| July 08, 2026 | 7.050 |
| July 07, 2026 | 7.050 |
| July 06, 2026 | 6.973 |
| July 02, 2026 | 6.973 |
| July 01, 2026 | 6.759 |
| June 30, 2026 | 6.759 |
| June 29, 2026 | 7.599 |
| June 26, 2026 | 7.599 |
| June 25, 2026 | 7.578 |
| June 24, 2026 | 7.462 |
| June 23, 2026 | 7.414 |
| June 22, 2026 | 6.985 |
| June 18, 2026 | 7.184 |
| June 17, 2026 | 7.184 |
| June 16, 2026 | 7.287 |
| June 15, 2026 | 7.178 |
| June 12, 2026 | 7.178 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Roche Holding AG | -- |
| Addex Therapeutics Ltd. | 0.9122 |
| Oculis Holding AG | 2.939 |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Price to Book Value Related Metrics
| PE Ratio | 24.69 |
| PS Ratio | 5.750 |
| Price to Free Cash Flow | 20.75 |
| Price | 163.60 |
| Earnings Yield | 4.05% |
| Market Cap | 299.48B |
| Operating PE Ratio | 19.44 |
| Normalized PE Ratio | 23.00 |